Elixhauser Comorbidity Measure and Charlson Comorbidity Index in Predicting the Death of Spanish Inpatients with Diabetes and Invasive Pneumococcal Disease

Invasive pneumococcal disease (IPD) is a serious infection caused by the bacterium <i>Streptococcus pneumoniae</i> (pneumococcus) that can produce a wide spectrum of clinical manifestations. The aim of this study was to analyze the comorbidity factors that influenced the mortality in pat...

書目詳細資料
發表在:	Microorganisms
Main Authors:	Enrique Gea-Izquierdo, Rossana Ruiz-Urbaez, Valentín Hernández-Barrera, Ángel Gil-de-Miguel
格式:	Article
語言:	英语
出版:	MDPI AG 2025-07-01
主題:	diabetes invasive pneumococcal disease comorbidity index retrospective study Spain
在線閱讀:	https://www.mdpi.com/2076-2607/13/7/1642

相似書籍

Elixhauser comorbidity method in predicting death of Spanish inpatients with asplenia and pneumococcal pneumonia
由: Enrique Gea-Izquierdo, et al.
出版: (2024-06-01)

Hospital burden of pneumococcal disease in Spain (2016–2022): A retrospective study
由: Ruth Gil-Prieto, et al.
出版: (2025-12-01)

The value of Age-adjusted Charlson and Elixhauser-Van Walraven comorbidity index in predicting prognosis for patients undergoing heart valve surgery
由: Xingping Lv, et al.
出版: (2024-10-01)

<i>Streptococcus pneumoniae</i> Infection in Patients with Asplenia: A Spanish Perspective over a 25-Year Period
由: Enrique Gea-Izquierdo, et al.
出版: (2024-01-01)

Charlson comorbidity index in predicting deaths in COVID-19 patients
由: A. V. Svarovskaya, et al.
出版: (2022-04-01)

Diabetes mellitus and invasive pneumococcal disease in Spain: a retrospective study
由: Enrique Gea-Izquierdo, et al.
出版: (2025-09-01)

Risk factors and comorbidities for invasive pneumococcal disease in Western Australian Aboriginal and non-Aboriginal people
由: Faye Janice Lim, et al.
出版: (2014-03-01)

Chronic medical conditions associated with invasive pneumococcal diseases in inpatients in teaching hospitals in São Paulo city: Estimating antimicrobial susceptibility and serotype-coverage of pneumococcal vaccines
由: Renato A. Kfouri, et al.
出版: (2023-03-01)

Charlson and Elixhauser Comorbidity Indices for Prediction of Mortality and Hospital Readmission in Patients With Acute Pulmonary Embolism
由: Alexander O’Hara MD, et al.
出版: (2024-05-01)

Adaptation of the Charlson Comorbidity Index for Register-Based Research in Sweden
由: Ludvigsson JF, et al.
出版: (2021-01-01)

The Comparison Of The Comorbidities Of Patients With Peritoneal Dialysis And Hemodialysis With The Charlson Comorbidity Index
由: Sevnur Aysal Sarı, et al.
出版: (2023-03-01)

Pneumococcal vaccination in adult patients with comorbidities: a review of the clinical practice guidelines
由: Kozlov R.S., et al.
出版: (2020-12-01)

The Ability of Comorbidity Indices to Predict Mortality After Heart Transplantation: A Validation of the Danish Comorbidity Index for Acute Myocardial Infarction, Charlson Comorbidity Index, and Elixhauser Comorbidity Index
由: Kasper Bonnesen, MD, et al.
出版: (2023-04-01)

Increasing Incremental Burden of Surgical Bleeding Associated with Multiple Comorbidities as Measured by the Elixhauser Comorbidity Index: A Retrospective Database Analysis
由: Afolabi M, et al.
出版: (2023-12-01)

Refining the Charlson Comorbidity Index for use in long-term care patients
由: Brijesh Sathian, et al.
出版: (2025-12-01)

Prognostic value of Charlson comorbidity index in patients admitted with acute myocardial infarction
由: Truong Huy Hoang, et al.
出版: (2024-06-01)

Analysis of the Impact of Comorbidities on Endometrial Lesions Using the Charlson Comorbidity Index in Western Romania
由: Alexandru Furau, et al.
出版: (2021-09-01)

Predictive value of the Elixhauser comorbidity index in assessing the risk of coronavirus disease (COVID-19) mortality in patients with pneumonia
由: I. O. Kuliesh, et al.
出版: (2025-02-01)

The use of Charlson comorbidity index for observational studies using administrative data in Korea
由: Dong Wook Shin, et al.
出版: (2025-03-01)

The Relationship between Post-COVID Syndrome and the Burden of Comorbidities Assessed Using the Charlson Comorbidity Index
由: Lorenzo Falsetti, et al.
出版: (2023-08-01)

Comorbidities and Complications in People Admitted for Leprosy in Spain, 1997–2021
由: Blanca Figueres-Pesudo, et al.
出版: (2024-05-01)

Psoriasis severity, comorbidity burden, and biologic therapy: a multicenter observational study using the Charlson Comorbidity Index
由: Nicoletta Bernardini, et al.
出版: (2025-12-01)

Discriminative Ability for Adverse Outcomes in Traumatic Ankle Fracture: A Comparison of the Modified Charlson Comorbidity Index, Elixhauser Comorbidity Measure, and Modified Frailty Index
由: Sanket Mehta, et al.
出版: (2022-11-01)

The Prognostic Value of the Age-Adjusted Charlson Comorbidity Index Among the Elderly with Breast Cancer
由: Wang Z, et al.
出版: (2023-07-01)

Application of Charlson Comorbidity Index to assess prognosis of 18-month mortality in patients with acute myocardial infarction
由: T. H. Hoang, et al.
出版: (2024-07-01)

Immunogenicity of pneumococcal vaccines in comorbid autoimmune and chronic respiratory diseases
由: Koji Kuronuma, et al.
出版: (2019-04-01)

Comparison of the performance of the CMS Hierarchical Condition Category (CMS-HCC) risk adjuster with the charlson and elixhauser comorbidity measures in predicting mortality
由: Li Pengxiang, et al.
出版: (2010-08-01)

The Risk of Invasive Pneumococcal Disease Differs between Risk Groups in Norway Following Widespread Use of the 13-Valent Pneumococcal Vaccine in Children
由: Brita Askeland Winje, et al.
出版: (2021-08-01)

Comorbidity in limited disease small-cell lung cancer: Age-adjusted Charlson comorbidity index and its association with overall survival following chemoradiotherapy
由: Christoph A. Fink, et al.
出版: (2023-09-01)

Burden of Hospitalizations Related to Pneumococcal Infection in Spain (2016–2020)
由: Ruth Gil-Prieto, et al.
出版: (2023-01-01)

The relationship of age-adjusted Charlson comorbidity ındex and diurnal variation of blood pressure
由: Belma Kalaycı, et al.
出版: (2019-02-01)

Predicting in-hospital mortality using Elixhauser comorbidity in patients underwent single and multiple coronary artery bypass surgery
由: Renxi Li, et al.
出版: (2024-06-01)

Comorbidity Burden Among Patients with Vitiligo in the United States: A Large-Scale Retrospective Claims Database Analysis
由: Khaled Ezzedine, et al.
出版: (2023-09-01)

Comorbidity profiles and pulmonary embolism risk assessment: Leveraging the Charlson Comorbidity Index for improved prognostication in a national data set
由: Truong‐An Ho, et al.
出版: (2024-10-01)

Development and validation of a prediction model based on comorbidities to estimate the risk of in-hospital death in patients with COVID-19
由: Yangjie Zhu, et al.
出版: (2023-05-01)

Economic Burden of Pneumococcal Disease in Individuals Aged 15 Years and Older in the Liguria Region of Italy
由: Matteo Astengo, et al.
出版: (2021-11-01)

Comorbidity Burden and Treatment Patterns of Psoriasis in Vietnam: Real-World Data from the EXPAND Study
由: Hao Trong Nguyen, et al.
出版: (2023-11-01)

Charlson Comorbidity Index in patients with systemic lupus erythematosus in Egypt and its relation with disease characteristics
由: Samah M Alian, et al.
出版: (2019-01-01)

The Charlson Comorbidity Index as a Predictor of mortality in hospitalized Covid-19 patients during the pandemic
由: Moslem Taheri Soodejani, et al.
出版: (2023-06-01)

Premorbid Comorbidities as Predictors of Outcome in Ischemic Posterior Fossa Stroke: A Retrospective Evaluation Using the Age-Adjusted Charlson Comorbidity Index
由: Francesca Culaj, et al.
出版: (2025-08-01)